Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00016237
Status:
COMPLETED
Last Update Posted:
2013-10-23
First Post:
2001-05-06
Brief Title:
Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney Bladder or Lung Cancer That Has Not Responded to Previous Treatment
Sponsor:
EMD Serono
Organization:
EMD Serono
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lung Cancer |
| Bladder Cancer |
| Kidney Cancer |
Keywords:
| Name | View |
|---|---|
| recurrent non-small cell lung cancer | View |
| squamous cell lung cancer | View |
| stage IV renal cell cancer | View |
| recurrent renal cell cancer | View |
| extensive stage small cell lung cancer | View |
| recurrent small cell lung cancer | View |
| recurrent bladder cancer | View |
| stage IV bladder cancer | View |
| stage IV non-small cell lung cancer | View |
| transitional cell carcinoma of the bladder | View |
| squamous cell carcinoma of the bladder | View |